ABSTRACT
The late onset of symptoms such as hearing defi ciency and psychomotor development delay in congenital infection with cytomegalovirus (CMV) can result in progressive and irreversible sequelae. Early diagnosis and follow-up of affected children are therefore essential for the detection and prevention of future problems (1) (2) . In newborns (NBs), the diagnosis can be made based on polymerase chain reaction (PCR) analysis of various clinical samples, among which urine is considered the gold standard. However, diffi culties in urine collection documented in some studies have led to a suggestion that saliva analysis may represent an easier, more practical, and less expensive approach (3) (4) . The aim of this large-scale neonatal screening study was to compare the effi ciency of saliva and urine samples analysis in detecting congenital infection with CMV.
This study included 1,000 NBs delivered at a public maternity hospital in Ilhéus, State of Bahia, from February to September 2012. Infants of any gestational age and clinical characteristics were included provided that a sample of urine or/and saliva was collected before the age of three weeks.
If viral deoxyribonucleic acid (DNA) was detected in at least two different samples, the infant was considered as having congenital CMV infection.
Saliva was collected with sterile swabs (Labor Swab, China) placed delicately on the inner surface of the cheek of the NB for 1 min. The swabs were then transferred to sterile plastic tubes containing 700µl of a transport medium (MEM Earle, Cultilab, USA). Urine samples were collected using hypoallergenic collecting bags (Mark Med, Brazil) and transferred to sterile plastic bottles. Samples of both types were kept at 4°C and subjected to PCR analysis within 24h. Viral genomes were detected by nested PCR using MIE4-MIE5 (5) external primers and IE1-IE2 (6) internal primers without prior extraction of DNA. Samples were incubated at 94°C for 5 min before the analysis.
Congenital CMV infection was detected by PCR analysis of urine or/and saliva in 13 (1.3%) NB, whereas the remaining 987 subjects were considered uninfected. The infected infants were subjected to hearing and sight tests as well as a complete physical examination. Twelve (92.3%) of them were asymptomatic and 1 (7.7%) had microcephaly.
It was not possible to obtain urine samples from 667/1,000 (66.7%) NBs because of difficulties such as meconium contamination, delay of diuresis, leakage of urine collector bags, and bag-induced skin irritation. In contrast, saliva samples were
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collected in 100% of the NBs, which refl ects the easiness with which they could be obtained.
Both urine and saliva were collected and analyzed in 333 cases, and congenital infection was detected in 5 of them (prevalence, 1.5%; 95% confi dence interval (CI), 0.6-3.4). In one case, infection was detected in the urine but not in the saliva. The strength of agreement between urine and saliva analysis, as assessed by a Kappa statistic, was very high (Kappa=0,887; p< 0.001). Congenital infections were detected in 8 out of the 667 NBs in whom only saliva was collected (prevalence, 1.2%; CI, 0.6-2.3). There was no statistically signifi cant difference between the use of saliva only (8/667; 1.2%; 95% CI, 0.5-3.0) or saliva and urine collected simultaneously (5/333; 1.5%; 95% CI 0.6-3.4) (p=0.70). Considering urine as the gold standard, the sensitivity and specifi city of saliva analysis were 80% and 100%, respectively, and the positive and negative predictive values were 100% and 99.7%, respectively.
The diffi culty in obtaining urine in a large-scale screening study can negatively affect the results because of the exclusion of many NBs from whom a sample cannot be obtained (7) (8) . Thus, we were unable to collect urine from two-thirds of the participating babies, which, had not saliva samples been collected, would have resulted in eight cases of CMV infection left undetected. Therefore, saliva samples procurement as an alternative to urine can dramatically (up to 100%) improve the inclusion index in neonatal screening for CMV. It was previously demonstrated that analysis of properly collected saliva samples can yield a sensitivity of >97% and a specifi city of 99.9% for the detection of congenital CMV infection with molecular techniques (3) . Our results are in line with these published values (specifi city of 100% for both samples).
No false-positive PCR results were obtained for saliva samples. In particular, all the positive results were confi rmed with viral DNA amplifi cation from the simultaneously obtained urine sample as well as new urine and saliva samples collected from the same child later. However, DNA amplifi cation from the urine sample revealed one case of false-negative result of saliva analysis. This could probably have occurred because of a problem during saliva collection, such as failure to wait for the appropriate amount of time for the swab to become properly moistened, sample collection immediately after breastfeeding, or contamination by a substance that inhibited the PCR. It has to be noted that a number of measures were taken to minimize the possibility of inhibition, such as heating, dilution, and centrifugation of the samples prior to analysis. Nevertheless, we cannot completely rule out the possibility of other false-negative results in the cases where urine samples were not collected. Previous studies also showed instances of false-negative detection of congenital CMV infection by PCR analysis of saliva and urine samples, which could have been caused by improper collection of the material or by the presence of metabolites, drugs, or other PCR-inhibiting substances (3) (7) .
Although few similar studies have been conducted in Bahia, the incidence of congenital CMV infection of 1.5% determined in the present study is in agreement with the results of studies performed in other regions of Brazil and other countries. Thus, the evaluation of 4,400 NBs from São Paulo revealed the prevalence of CMV DNA detection by PCR of 1.1% in urine and saliva samples 7 . Furthermore, Paixão et al. obtained a congenital CMV infection prevalence of 1.05% (CI 95%: 0,748-1,446) using dried blood spot testing (Guthrie cards) in 3,600 Portuguese NBs performed over a period of 14 months (8) .
In conclusion, saliva seems to represent a viable alternative to urine, the gold-standard material for congenital CMV infection screening, owing to the ease of collection combined with comparable sensitivity and specifi city. Moreover, the use of saliva may result in the inclusion of up to 100% of the participating children, allowing the detection of a higher number of congenital infection cases.
Ethical considerations
The study was approved by the Committee of ethics in research with Human Beings of the Universidade Estadual de Santa Cruz (UESC), Protocol 209/08. All mothers or guardians of the NBs provided written informed consent.
